AI diagnostics research: liver cancer blood test, bowel cancer relapse risk, Parkinson's eye scans, sleep studies
An AI-based blood assay detected liver cancer across several international populations. AI flags hidden relapse risk in stage II bowel cancer from pathology slides (La Trobe), and UW Medicine's AI identifies health risks from routine sleep study data.
Who is affected and how
- doctor
- The studies point to widening screening and risk-assessment methods, and their clinical use requires further validation.
Sources
- AI Blood Assay Detects Liver Cancer Across Diverse International Populationstechnology networks · Aug 3, 2026
- AI blood assay detects liver cancer across diverse international populations - ecancerecancer.org · Aug 4, 2026
- AI flags hidden relapse risk in stage II bowel cancer - The Gut Republicgutrepublic.com.au · Aug 4, 2026
- La Trobe AI flags bowel cancer recurrence risk - MobiHealthNewsmobihealthnews.com · Aug 7, 2026
- La Trobe develops AI tool to predict bowel cancer relapse using routine pathology slides | Noah Intelligencenoah-news.com · Aug 7, 2026 · magyar
- International Research Asks: Can AI Detect Parkinson’s Disease from Eye Scans?news.cuanschutz.edu · Aug 4, 2026 · magyar
- International research asks: Can AI detect Parkinson’s disease from eye scans? | EurekAlert!eurekalert.org · Aug 6, 2026
- AI identifies health risks from routine sleep study data - UW Medicine | Newsroomnewsroom.uw.edu · Aug 3, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.